<SEC-DOCUMENT>0001815776-24-000018-index.html : 20240325
<SEC-HEADER>0001815776-24-000018.hdr.sgml : 20240325
<ACCEPTANCE-DATETIME>20240325202656
ACCESSION NUMBER:		0001815776-24-000018
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20240321
FILED AS OF DATE:		20240325
DATE AS OF CHANGE:		20240325

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			MCCOLLUM JAMES W
		CENTRAL INDEX KEY:			0001200889
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40532
		FILM NUMBER:		24780676

	MAIL ADDRESS:	
		STREET 1:		C/O LENZ THERAPEUTICS, INC.
		STREET 2:		445 MARINE VIEW AVE SUITE 320
		CITY:			DEL MAR
		STATE:			CA
		ZIP:			92014

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LENZ Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001815776
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				844867570
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		445 MARINE VIEW AVE SUITE 320
		CITY:			DEL MAR
		STATE:			CA
		ZIP:			92014
		BUSINESS PHONE:		858-925-7000

	MAIL ADDRESS:	
		STREET 1:		445 MARINE VIEW AVE SUITE 320
		CITY:			DEL MAR
		STATE:			CA
		ZIP:			92014

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Graphite Bio, Inc.
		DATE OF NAME CHANGE:	20210312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Integral Medicines, Inc.
		DATE OF NAME CHANGE:	20200622
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>wk-form3_1711412806.xml
<DESCRIPTION>FORM 3
<TEXT>
Document 1 - file: wk-form3_1711412806.html

Document 1 - RAW XML: wk-form3_1711412806.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>mccollumpoa.htm
<DESCRIPTION>EX-24
<TEXT>
Document 2 - file: mccollumpoa.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>mccollumpoa001.jpg
<TEXT>
Document 3 - file: mccollumpoa001.jpg

</DOCUMENT>
</SEC-DOCUMENT>